纳米药物递送系统的设计:教训与思考

来源 :中国微米纳米技术学会纳米科学技术分会第四届年会暨2016国际纳米生物与医学学术会议 | 被引量 : 0次 | 上传用户:slb135
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
其他文献
Therapeutic biomacromolecules such as proteins and peptides have been gaining increased popularity to treat various diseases since 1970s(1).This significantly increases the demand of simple routes of
Glioma is a malignant primary tumor with the highest intracranial incidence.It is also among the top three cancers,which are of the highest mortality,including pancreatic cancer and lung cancer.At pre
会议
Highly precise structures and intelligently self-regulated function were of fundamental importance for nanoparticles to enhance cancer therapy.[1] In the design of nanoparticle-based anticancer nanome
Successful therapy of cancer has been seriously hindered by the insolubility and instability of antitumor drugs,and more critically,by the nonspecific delivery and poor penetration of drug formulation
会议
Drug delivery systems(DDS),based on particulate carriers(primarily composed of lipids or polymers),have demonstrated its superiority in preclinical tumor diagnosis and therapeutic treatment compared w
Liposomes have already had a major impact on improving the druggability,especially the application in antitumor drugs.Liposome-based drugs carved out a sizeable share of anticancer nanomedicines clini
In the past decade,nanoparticle-based drug delivery systems,such as gold nanoparticles,mesoporous silica nanoparticles(MSNs)and upconversion nanoparticles,have been extensively investigated for the tr